Santen SAS

🇫🇷France
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.santen.eu/fr

3 Month Study of Cationorm Pro Versus Vismed in Adults With Dry Eye Disease Related to Keratitis or Keratoconjunctivitis

Not Applicable
Recruiting
Conditions
Interventions
First Posted Date
2021-01-08
Last Posted Date
2024-04-19
Lead Sponsor
Santen SAS
Target Recruit Count
80
Registration Number
NCT04701086
Locations
🇫🇷

CHRU Bretonneau, Tours, France

🇫🇷

Cabinet Liberal, La Rochefoucauld, France

🇵🇱

Gabinet Okulistyczny, Bielsko-Biala, Poland

and more 7 locations

3 Month Study of Alocross Versus Vismed in Adults With Dry Eye Disease Related to Keratitis or Keratoconjunctivitis

Not Applicable
Recruiting
Conditions
Interventions
First Posted Date
2020-12-28
Last Posted Date
2024-04-19
Lead Sponsor
Santen SAS
Target Recruit Count
80
Registration Number
NCT04685109
Locations
🇫🇷

Institut Ophtalmologique Ouest Jules Verne, Nantes, France

🇫🇷

Cabinet D'Ophtalmologie Foch, Bordeaux, France

🇫🇷

Hopital Pasteur 2, Nice, France

and more 8 locations

3-year Study in Dry Eye Disease Patients With Severe Keratitis Receiving Ikervis® (1mg/mL Ciclosporin)

First Posted Date
2019-10-30
Last Posted Date
2024-08-28
Lead Sponsor
Santen SAS
Target Recruit Count
350
Registration Number
NCT04144413
Locations
🇫🇷

Hopitaux Universitaires Paris-Sud - Hopital Bicetre, Le Kremlin-Bicêtre, Île-de-France, France

🇫🇷

Hôpital des Quinze-Vingts, Paris, Île-de-France, France

🇫🇷

Hopitaux Universitaires Paris Nord Val de Seine - Hopital Bichat - Claude Bernard, Paris, Île-de-France, France

and more 42 locations

Effect of IKERVIS® Eye Drops Once Daily on the Quality of Vision in Dry Eye Disease Patients With Severe Keratitis

Phase 4
Completed
Conditions
Interventions
First Posted Date
2017-08-03
Last Posted Date
2024-04-18
Lead Sponsor
Santen SAS
Target Recruit Count
17
Registration Number
NCT03237936
Locations
🇫🇷

CHU de Brest, Brest, France

Double-Masked Trial of NOVA22007 (1mg/mL Ciclosporin/Cyclosporine) Versus Vehicle in Pediatric Patients With Active Severe Vernal Keratoconjunctivitis

First Posted Date
2012-12-17
Last Posted Date
2022-03-28
Lead Sponsor
Santen SAS
Target Recruit Count
169
Registration Number
NCT01751126
Locations
🇺🇸

Glendale, CA, USA, Glendale, California, United States

🇺🇸

Rancho Cordova, CA, USA, Rancho Cordova, California, United States

🇬🇷

Thessaloniki, Macedonia, GR, Thessaloniki, Macedonia, Greece

and more 40 locations

Safety and Efficacy Study of Catioprost® (Unpreserved Latanoprost 0.005% Emulsion) Compared to Travatan Z® to Treat Glaucoma and Ocular Surface Disease

First Posted Date
2010-12-06
Last Posted Date
2016-06-06
Lead Sponsor
Santen SAS
Target Recruit Count
105
Registration Number
NCT01254370
Locations
🇺🇸

Ora (Ophthalmic Research Associates), Andover, Massachusetts, United States

Double-Masked Trial of NOVA22007 (Ciclosporin 0.1%) Versus Vehicle in Patients With Moderate to Severe Dry Eye Syndrome

First Posted Date
2008-12-25
Last Posted Date
2010-07-16
Lead Sponsor
Santen SAS
Target Recruit Count
482
Registration Number
NCT00814515
Locations
🇫🇷

Hôpital des XV-XX, Paris, Île-de-France, France

NOVA22007 0.05% and 0.1% Cyclosporine Versus Vehicle for the Treatment of Dry Eye

First Posted Date
2008-08-21
Last Posted Date
2016-06-06
Lead Sponsor
Santen SAS
Target Recruit Count
132
Registration Number
NCT00739349
Locations
🇺🇸

Central Maine Eye Care, PA, Lewiston, Maine, United States

© Copyright 2024. All Rights Reserved by MedPath